Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $118
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $170 to $118.
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $170 to $118.